Application of Ectoin Allergy Nasal Spray in Comparison to Beclomethasone Nasal Spray

Bitop

Status: Completed

Conditions: Allergic Rhinitis

Treatments: Other: Medical Device, drug-like; Drug: Beclomethasone

Study type: Observational

Funder types: Industry

Identifiers

NCT02133053

PPL-042

Details and patient eligibility

About

This is a comparative, open label, parallel group, non interventional study to further demonstrate the effectiveness and tolerability of Ectoin® Allergy Nasal Spray. In addition the effectiveness and safety shall be compared to a Beclomethasone nasal spray. The patient applies Ectoin® Rhinitis Nasal Spray or Beclomethasone nasal spray according to the instructions for use. The observation takes place over a period of 14 days. Response to treatment is recorded at day 7 and day 14 by the physician and in daily by the patient in a dairy.

Enrollment: 50 patients

Sex: All

Ages: 18 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosed allergic rhinitis during the observational period

Exclusion criteria

• Contra indications according to the label

Trial design

50 participants in 2 patient groups

Ectoin Group

Description:

Ectoin Allergy Nasal Spray (Medical Device, drug-like)

Treatment:

Other: Medical Device, drug-like

Beclomethasone Group

Description:

Beclomethasone nasal spray

Treatment:

Drug: Beclomethasone